Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Ceribelli

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|March 17, 2022
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue DiseaseAngela Ceribelli, Natasa Isailovic, Carolina Gorlino, et al.
Frontiers in Immunology|September 27, 2023
Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosisFrancesca Motta, Antonio Tonutti, Natasa Isailovic, et al.
Arthritis Research & Therapy|July 27, 2011
MicroRNAs in systemic rheumatic diseasesAngela Ceribelli, Bing Yao, Paul R Dominguez-Gutierrez, et al.
International Journal of Molecular Sciences|September 27, 2025
Detection and Clinical Associations of Autoantibodies to Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A2/B1 in Patients with Systemic SclerosisAntonio Tonutti, Natasa Isailovic, Lukas Frischknecht, et al.
Arthritis Research & Therapy|January 24, 2014
Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosusPaul R Dominguez-Gutierrez, Angela Ceribelli, Minoru Satoh, et al.
Journal of Autoimmunity|April 8, 2020
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapyAngela Ceribelli, Francesca Motta, Maria De Santis, et al.
Journal of Immunological Methods|February 25, 2016
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis seraIlaria Cavazzana, Micaela Fredi, Angela Ceribelli, et al.
Arthritis Research & Therapy|January 28, 2014
Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subsetPaul R Dominguez-Gutierrez, Angela Ceribelli, Minoru Satoh, et al.
Journal of Clinical Immunology|December 3, 2013
Positive correlation of STAT1 and miR-146a with anemia in patients with systemic lupus erythematosusPaul R Dominguez-Gutierrez, Angela Ceribelli, Minoru Satoh, et al.
RMD Open|September 21, 2024
Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosisAntonio Tonutti, Francesca Motta, Natasa Isailovic, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|March 17, 2022
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue DiseaseAngela Ceribelli, Natasa Isailovic, Carolina Gorlino, et al.
Frontiers in Immunology|September 27, 2023
Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosisFrancesca Motta, Antonio Tonutti, Natasa Isailovic, et al.
Arthritis Research & Therapy|July 27, 2011
MicroRNAs in systemic rheumatic diseasesAngela Ceribelli, Bing Yao, Paul R Dominguez-Gutierrez, et al.
International Journal of Molecular Sciences|September 27, 2025
Detection and Clinical Associations of Autoantibodies to Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A2/B1 in Patients with Systemic SclerosisAntonio Tonutti, Natasa Isailovic, Lukas Frischknecht, et al.
Arthritis Research & Therapy|January 24, 2014
Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosusPaul R Dominguez-Gutierrez, Angela Ceribelli, Minoru Satoh, et al.
Journal of Autoimmunity|April 8, 2020
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapyAngela Ceribelli, Francesca Motta, Maria De Santis, et al.
Journal of Immunological Methods|February 25, 2016
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis seraIlaria Cavazzana, Micaela Fredi, Angela Ceribelli, et al.
Arthritis Research & Therapy|January 28, 2014
Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subsetPaul R Dominguez-Gutierrez, Angela Ceribelli, Minoru Satoh, et al.
Journal of Clinical Immunology|December 3, 2013
Positive correlation of STAT1 and miR-146a with anemia in patients with systemic lupus erythematosusPaul R Dominguez-Gutierrez, Angela Ceribelli, Minoru Satoh, et al.
RMD Open|September 21, 2024
Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosisAntonio Tonutti, Francesca Motta, Natasa Isailovic, et al.
Pageof 11